1059 related articles for article (PubMed ID: 26839260)
1. IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.
Munn DH; Mellor AL
Trends Immunol; 2016 Mar; 37(3):193-207. PubMed ID: 26839260
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase and tumor-induced tolerance.
Munn DH; Mellor AL
J Clin Invest; 2007 May; 117(5):1147-54. PubMed ID: 17476344
[TBL] [Abstract][Full Text] [Related]
3. Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.
Johnson TS; Mcgaha T; Munn DH
Adv Exp Med Biol; 2017; 1036():91-104. PubMed ID: 29275467
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
5. IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.
Munn DH; Sharma MD; Johnson TS; Rodriguez P
Cancer Immunol Immunother; 2017 Aug; 66(8):1049-1058. PubMed ID: 28488123
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation.
Munn DH
Curr Opin Immunol; 2006 Apr; 18(2):220-5. PubMed ID: 16460921
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
[TBL] [Abstract][Full Text] [Related]
8. Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.
Davar D; Bahary N
Target Oncol; 2018 Apr; 13(2):125-140. PubMed ID: 29302770
[TBL] [Abstract][Full Text] [Related]
9. Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?
Löb S; Königsrainer A
Langenbecks Arch Surg; 2008 Nov; 393(6):995-1003. PubMed ID: 18064486
[TBL] [Abstract][Full Text] [Related]
10. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance.
Trabanelli S; Ocadlikova D; Evangelisti C; Parisi S; Curti A
Curr Med Chem; 2011; 18(15):2234-9. PubMed ID: 21517756
[TBL] [Abstract][Full Text] [Related]
11. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
[TBL] [Abstract][Full Text] [Related]
12. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy.
Johnson BA; Baban B; Mellor AL
Immunotherapy; 2009 Jul; 1(4):645-61. PubMed ID: 20161103
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies.
Selvan SR; Dowling JP; Kelly WK; Lin J
Curr Cancer Drug Targets; 2016; 16(9):755-764. PubMed ID: 26517538
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase in immune suppression and cancer.
Muller AJ; Prendergast GC
Curr Cancer Drug Targets; 2007 Feb; 7(1):31-40. PubMed ID: 17305476
[TBL] [Abstract][Full Text] [Related]
15. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase in tumor induced tolerance.
Liu XQ; Wang X
Chin Med J (Engl); 2009 Dec; 122(24):3072-7. PubMed ID: 20137504
[TBL] [Abstract][Full Text] [Related]
18. The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase.
Andersen MH
Cancer Immunol Immunother; 2012 Aug; 61(8):1289-97. PubMed ID: 22388712
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase, Tregs and cancer.
Munn DH
Curr Med Chem; 2011; 18(15):2240-6. PubMed ID: 21517755
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
